There are 3164 resources available
Focusing on long term benefits: insights from NALLONG study
Presenter: Jean-Luc van Laethem
Session: Servier - Advancements in Metastatic Pancreatic Cancer: Which perspectives for patients?
Resources:
Webcast
Panel discussion
Presenter: Patrizia Giannatempo, Alison Birtle, Alejo Rodriguez-Vida, Elena Verzoni
Session: Johnson & Johnson - Optimising the personalisation of GU cancer care
Resources:
Webcast
Q&A
Presenter: Neal Shore, Axel Merseburger, Eleni Efstathiou
Session: Pfizer Oncology - Breaking new ground: PARPi + ARPi combination therapy in mCRPC
Resources:
Webcast
Exploring Recent Clinical Data: Perspectives from the Japanese Experience
Presenter: Masafumi Ikeda
Session: Servier - Advancements in Metastatic Pancreatic Cancer: Which perspectives for patients?
Resources:
Webcast
The evolving patient pathway in mUC: What do the changing guidelines mean for treatment sequencing?
Presenter: Simon Crabb
Session: Johnson & Johnson - Optimising the personalisation of GU cancer care
Resources:
Webcast
Conclusion
Presenter: Neal Shore
Session: Pfizer Oncology - Breaking new ground: PARPi + ARPi combination therapy in mCRPC
Resources:
Webcast
Panel discussion
Presenter: Eric Van Cutsem, Teresa Macarulla Mercade, Gerald Prager, Jean-Luc van Laethem, Masafumi Ikeda
Session: Servier - Advancements in Metastatic Pancreatic Cancer: Which perspectives for patients?
Resources:
Webcast
FGFR testing: Why, how, when?
Presenter: Viktor Gruenwald
Session: Johnson & Johnson - Optimising the personalisation of GU cancer care
Resources:
Webcast
Conclusion
Presenter: Teresa Macarulla Mercade
Session: Servier - Advancements in Metastatic Pancreatic Cancer: Which perspectives for patients?
Resources:
Webcast
Optimising patient care: Managing adverse events
Presenter: Simon Crabb, Viktor Gruenwald
Session: Johnson & Johnson - Optimising the personalisation of GU cancer care
Resources:
Webcast